BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15050477)

  • 1. Prognostic factors for survival of epithelial ovarian cancer.
    Linasmita V; Pattaraarchachai J; Daengdeelert P
    Int J Gynaecol Obstet; 2004 Apr; 85(1):66-9. PubMed ID: 15050477
    [No Abstract]   [Full Text] [Related]  

  • 2. [Epithelial ovarian cancer: what is the consensus in 1995?].
    Chevallier B; Dessogne P
    Bull Cancer; 1995 Nov; 82(11):923-8. PubMed ID: 8535018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of second-look laparotomy for surgically confirmed early-stage epithelial ovarian cancer: a multicenter retrospective study.
    Sato N; Akahira J; Kitamura T; Aoki M; Yoshinaga K; Okamura C; Utsunomiya H; Shimizu T; Niikura H; Ito K; Okamura K; Yaegashi N
    Int J Clin Oncol; 2003 Feb; 8(1):40-4. PubMed ID: 12601541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epithelial ovarian cancer - a change of paradigm].
    Heinzelmann-Schwarz V
    Ther Umsch; 2011 Oct; 68(10):565-72. PubMed ID: 21968896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors of epithelial ovarian cancer in young women].
    Zhang R; Wu LY; Zhang WH; Li HJ; Li SM; Liu LY
    Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):264-7. PubMed ID: 12839691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation and prognostic value of serum plasminogen activator inhibitor-1 before and after chemotherapy in patients with epithelial ovarian cancer.
    Chen S; Tai H; Tong X; Wang J; Yang F; Yang Y; Yiqin O
    J Obstet Gynaecol Res; 2014 Sep; 40(9):2058-65. PubMed ID: 25181626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newly and relapsed epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Aebi S; Castiglione M;
    Ann Oncol; 2009 May; 20 Suppl 4():21-3. PubMed ID: 19454452
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of geographic variations in treatment on outcomes in ovarian cancer.
    Dehaeck U; McGahan CE; Santos JL; Carey MS; Swenerton KD; Kwon JS
    Int J Gynecol Cancer; 2013 Feb; 23(2):282-7. PubMed ID: 23295939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathology of malignant surface epithelial neoplasms of the ovary.
    Hendrickson MR; Longacre TA; Kempson RL
    Pathology (Phila); 1993; 1(2):367-410. PubMed ID: 9420924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment and prognostic factors for stage IV epithelial ovarian cancer].
    Wu M; Shen K; Lang J
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):200-3. PubMed ID: 11776158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the Effects of Time to Diagnosis, Income, Symptoms, and Incidental Detection on Overall Survival in Epithelial Ovarian Cancer: Manitoba Ovarian Cancer Outcomes (MOCO) Study Group.
    Altman AD; Lambert P; Love AJ; Turner D; Lotocki R; Dean E; Popowich S; Nachtigal MW
    Int J Gynecol Cancer; 2017 Oct; 27(8):1637-1644. PubMed ID: 28704327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular localization and protein levels of cyclin-dependent kinase inhibitor p27 independently predict for survival in epithelial ovarian cancer.
    Psyrri A; Bamias A; Yu Z; Weinberger PM; Kassar M; Markakis S; Kowalski D; Efstathiou E; Camp RL; Rimm DL; Dimopoulos MA
    Clin Cancer Res; 2005 Dec; 11(23):8384-90. PubMed ID: 16322299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of risk factors for epithelial ovarian cancer recurrence].
    Liu S; Liu JH; Huang H; Peng XP; Wang YM
    Ai Zheng; 2003 Nov; 22(11):1197-200. PubMed ID: 14613652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer.
    Hennessy BT; Coleman RL; Markman M
    Lancet; 2009 Oct; 374(9698):1371-82. PubMed ID: 19793610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, mortality, and survival trends of ovarian cancer in Hong Kong, 1997 to 2006: a population-based study.
    Wong KH; Mang OW; Au KH; Law SC
    Hong Kong Med J; 2012 Dec; 18(6):466-74. PubMed ID: 23223646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of reproductive and hormonal factors on ovarian cancer survival.
    Nagle CM; Bain CJ; Green AC; Webb PM
    Int J Gynecol Cancer; 2008; 18(3):407-13. PubMed ID: 17645507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment of recurrent epithelial ovarian carcinoma].
    Wu XF; Chen HZ; Han DF
    Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):664-6. PubMed ID: 14728851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year relative survival for epithelial ovarian cancer.
    Baldwin LA; Huang B; Miller RW; Tucker T; Goodrich ST; Podzielinski I; DeSimone CP; Ueland FR; van Nagell JR; Seamon LG
    Obstet Gynecol; 2012 Sep; 120(3):612-8. PubMed ID: 22914471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited prognostic value of tissue protein expression levels of cyclin E in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study.
    Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Blaakaer J; Christensen IJ; Hogdall EV
    APMIS; 2012 Oct; 120(10):846-54. PubMed ID: 22958293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer.
    Spentzos D; Cannistra SA; Grall F; Levine DA; Pillay K; Libermann TA; Mantzoros CS
    Endocr Relat Cancer; 2007 Sep; 14(3):781-90. PubMed ID: 17914107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.